Our Commitment to Diversity & Inclusion
To deliver better outcomes for our people, patients, business and communities, we must be intentional and bold.
Pioneering Change At Genentech
Our commitments are clear: fostering belonging for our people, advancing inclusive research and health equity to improve patient outcomes, and transforming society by investing in a diverse STEM talent pipeline and supplier partnerships. Our initiatives and investments, driven by strong cross-sector collaborations, are not mere actions but a movement to create lasting change. We're setting industry benchmarks and ensuring our strategy for D&I shapes a more equitable healthcare landscape for all. Our blueprint, which is a testament to our long-standing resolve and years of learning, has laid the foundation to guide us towards our 2025 Commitments and beyond.
![Smiling photo of TERESA GRAHAM, Chief Executive Officer, Roche Pharmaceuticals](/assets/images/people/Teresa-Graham-Headshot.jpg)
![Smiling photo of ASHLEY MAGARGEE, Chief Executive Officer, Genentech](/assets/images/people/Ashley-Magargee-Headshot.jpg)
![Smiling photo of QUITA HIGHSMITH, Vice President, Chief Diversity Officer, Genentech](/assets/images/people/Quita-Highsmith-Headshot.jpg)
Our 2025 Commitments
Levi Garraway, M.D., PH.D.
Executive Vice President, Head of Global Product Development and Chief Medical Officer, Genentech
Inclusive Research®
& Health Equity
Fritz Bittenbender
Senior Vice President and Head, Genentech Public Affairs and Access, Genentech
Belonging